Z. Tellier

1.6k total citations
31 papers, 1.1k citations indexed

About

Z. Tellier is a scholar working on Hematology, Epidemiology and Hepatology. According to data from OpenAlex, Z. Tellier has authored 31 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 8 papers in Epidemiology and 7 papers in Hepatology. Recurrent topics in Z. Tellier's work include Platelet Disorders and Treatments (8 papers), Liver Disease Diagnosis and Treatment (8 papers) and Liver Disease and Transplantation (6 papers). Z. Tellier is often cited by papers focused on Platelet Disorders and Treatments (8 papers), Liver Disease Diagnosis and Treatment (8 papers) and Liver Disease and Transplantation (6 papers). Z. Tellier collaborates with scholars based in France, United Kingdom and United States. Z. Tellier's co-authors include Richard Moreau, Didier Lebrec, Éric Ogier‐Denis, Cécile Guichard, Luc Mouthon, P Hurteloup, Loı̈c Guillevin, B. Pignon, Francis Witz and Jean‐Luc Harousseau and has published in prestigious journals such as Blood, Hepatology and Biophysical Journal.

In The Last Decade

Z. Tellier

30 papers receiving 1.1k citations

Peers

Z. Tellier

HEMAT

EPIDE

HEPAT

SURGE

Frank S. Fan Taiwan

Michela Ribersani Italy

Josep Martí Spain

Dominique Challine France

E. Dybkjær Denmark

H W Hann United States

G Duhamel France

Noga Manny Israel

Tsu‐Yi Chao Taiwan

Brian Susskind United States

Frank S. Fan Taiwan

Z. Tellier

217 ×0.4

HEMAT

298 ×0.9

EPIDE

194 ×0.7

HEPAT

256 ×1.3

366 ×2.2

SURGE

Citations per year, relative to Z. Tellier Z. Tellier (= 1×) peers Frank S. Fan

Countries citing papers authored by Z. Tellier

Since Specialization

Citations

This map shows the geographic impact of Z. Tellier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Z. Tellier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Z. Tellier more than expected).

Fields of papers citing papers by Z. Tellier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Z. Tellier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Z. Tellier. The network helps show where Z. Tellier may publish in the future.

Co-authorship network of co-authors of Z. Tellier

This figure shows the co-authorship network connecting the top 25 collaborators of Z. Tellier. A scholar is included among the top collaborators of Z. Tellier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Z. Tellier. Z. Tellier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tellier, Z., et al.. (2019). Aggregates Dramatically Alter Fibrin Ultrastructure. Biophysical Journal. 118(1). 172–181. 8 indexed citations

Elalamy, Ismaı̈l, et al.. (2019). Argatroban et thrombopénie induite par l’héparine : observatoire des modalités de prescription et d’utilisation en France. Therapies. 75(6). 543–552.

Négrier, Claude, A.‐S. Ducloy‐Bouthors, Vincent Piriou, et al.. (2017). Postauthorization safety study of Clottafact^®, a triply secured fibrinogen concentrate in acquired fibrinogen deficiency: a prospective observational study. Vox Sanguinis. 113(2). 120–127. 8 indexed citations

Chevreux, Guillaume, Valegh Faid, M. André, Z. Tellier, & Nicolas Bihoreau. (2012). Differential investigations from plasma‐derived and recombinant Factor IX revealed major differences in post‐translational modifications of activation peptides. Vox Sanguinis. 104(2). 171–174. 9 indexed citations

André, M., et al.. (2012). A qualitative and quantitative analysis of von Willebrand factor contained in a very high‐purity plasma‐derived FVIII concentrate. Vox Sanguinis. 103(1). 35–41. 3 indexed citations

Coant, Nicolas, Thierry Gustot, Magali Fasseu, et al.. (2011). Glycogen synthase kinase 3 involvement in the excessive proinflammatory response to LPS in patients with decompensated cirrhosis. Journal of Hepatology. 55(4). 784–793. 44 indexed citations

Asselah, Tarik, Ivan Bièche, Abdellah Mansouri, et al.. (2010). In vivo hepatic endoplasmic reticulum stress in patients with chronic hepatitis C. The Journal of Pathology. 221(3). 264–274. 107 indexed citations

Tellier, Z., M. André, & Benoı̂t Polack. (2009). Management of Haemophilia A-Inhibitor Patients: Clinical and Regulatory Perspectives. Clinical Reviews in Allergy & Immunology. 37(2). 125–134. 8 indexed citations

Galbois, Arnaud, Dominique Thabut, Khalid A. Tazi, et al.. (2008). Ex vivo effects of high‐density lipoprotein exposure on the lipopolysaccharide‐induced inflammatory response in patients with severe cirrhosis†. Hepatology. 49(1). 175–184. 56 indexed citations

10.

Tellier, Z.. (2007). Human Immunoglobulins in Intraocular Inflammation. Annals of the New York Academy of Sciences. 1110(1). 337–347. 13 indexed citations

11.

Tazi, Khalid A., Ivan Bièche, Valérie Paradis, et al.. (2007). In vivo altered unfolded protein response and apoptosis in livers from lipopolysaccharide-challenged cirrhotic rats. Journal of Hepatology. 46(6). 1075–1088. 45 indexed citations

12.

Delignat, Sandrine, Suryasarathi Dasgupta, Sébastien André, et al.. (2007). Comparison of the immunogenicity of different therapeutic preparations of human factor VIII in the murine model of hemophilia A. Haematologica. 92(10). 1423–1426. 36 indexed citations

13.

Dreyfus, Marie, Hérvè Chambost, Y. Gruel, et al.. (2007). Treatment of inherited protein C deficiency by replacement therapy with the French purified plasma‐derived protein C concentrate (PROTEXEL®). Vox Sanguinis. 93(3). 233–240. 9 indexed citations

14.

Borel‐Derlon, Annie, Augusto B. Federici, V. Roussel‐Robert, et al.. (2007). Treatment of severe von Willebrand disease with a high‐purity von Willebrand factor concentrate (Wilfactin®): a prospective study of 50 patients. Journal of Thrombosis and Haemostasis. 5(6). 1115–1124. 83 indexed citations

15.

Moreau, Richard, Dominique Valla, Isabelle Durand‐Zaleski, et al.. (2005). Comparison of outcome in patients with cirrhosis and ascites following treatment with albumin or a synthetic colloid:. Liver International. 26(1). 46–54. 69 indexed citations

16.

Goudemand, Jenny, I. Scharrer, Erik Berntorp, et al.. (2005). Pharmacokinetic studies on Wilfactin®, a von Willebrand factor concentrate with a low factor VIII content treated with three virus-inactivation/removal methods. Journal of Thrombosis and Haemostasis. 3(10). 2219–2227. 64 indexed citations

17.

Tellier, Z.. (2005). Intravenous immunogloblins: myth and reality.. PubMed. 7(12). 762–7. 1 indexed citations

18.

Tellier, Z.. (2005). Intravenous Immunoglobulin in Eye Involvement. Clinical Reviews in Allergy & Immunology. 29(3). 295–306. 5 indexed citations

19.

Mouthon, Luc, Loı̈c Guillevin, & Z. Tellier. (2004). Intravenous immunoglobulins in autoimmune- or parvovirus B19-mediated pure red-cell aplasia. Autoimmunity Reviews. 4(5). 264–269. 49 indexed citations

20.

Tellier, Z. & Luc Mouthon. (2003). Les indications thérapeutiques des immunoglobulines intraveineuses. Transfusion Clinique et Biologique. 10(3). 179–184. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact